Bulletin
Investor Alert

Market Pulse Archives

May 12, 2021, 7:12 a.m. EDT

Moderna's new supply deal with Australia is for 25 million COVID-19 vaccine doses

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Moderna Inc. /zigman2/quotes/205619834/composite MRNA -1.62% announced Wednesday a new agreement to supply 25 million doses of its COVID-19 vaccine to Australia. The agreement includes 10 million doses of the biotechnology company's mRNA-1273 vaccine to be delivered this year and 15 million doses of its variant booster vaccine candidate to be delivered in 2022. The agreement is subject to approval of mRNA-1273 and the booster vaccine candidate by Australia's Therapeutic Goods Administration. Moderna's stock, which fell 0.2% in premarket trading, has run up 52.2% year to date through Tuesday, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.31% has gained 10.5%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 199.19
-3.28 -1.62%
Volume: 6.66M
June 18, 2021 4:00p
P/E Ratio
158.84
Dividend Yield
N/A
Market Cap
$79.98 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,166.45
-55.41 -1.31%
Volume: 3.62B
June 18, 2021 5:09p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.